267 related articles for article (PubMed ID: 26682730)
1. Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Chen J; Xia Q; Jiang B; Chang W; Yuan W; Ma Z; Liu Z; Shu X
PLoS One; 2015; 10(12):e0145164. PubMed ID: 26682730
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinical value of Sirt1 expression in gastric cancer: A systematic meta-analysis.
Jiang B; Chen JH; Yuan WZ; Ji JT; Liu ZY; Wu L; Tang Q; Shu XG
J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):278-284. PubMed ID: 27072976
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
Zhou C; Sun B
Oral Oncol; 2014 Dec; 50(12):1144-8. PubMed ID: 25264224
[TBL] [Abstract][Full Text] [Related]
5. The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
Vogler T; Kriegl L; Horst D; Engel J; Sagebiel S; Schäffauer AJ; Kirchner T; Jung A
Exp Mol Pathol; 2012 Feb; 92(1):111-7. PubMed ID: 22101256
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase 1: a specific cancer stem cell marker for human colorectal carcinoma.
Zhou F; Mu YD; Liang J; Liu ZX; Zhou D; Ning WL; Li YZ; Ding D; Zhang JF
Mol Med Rep; 2015 May; 11(5):3894-9. PubMed ID: 25585687
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.
Morise M; Hishida T; Takahashi A; Yoshida J; Ohe Y; Nagai K; Ishii G
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2121-30. PubMed ID: 25963795
[TBL] [Abstract][Full Text] [Related]
8. ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis.
Wei D; Peng JJ; Gao H; Zhang T; Tan Y; Hu YH
Heart Lung Circ; 2015 Aug; 24(8):780-8. PubMed ID: 25921687
[TBL] [Abstract][Full Text] [Related]
9. Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
Miyoshi Y; Shien T; Ogiya A; Ishida N; Yamazaki K; Horii R; Horimoto Y; Masuda N; Yasojima H; Inao T; Osako T; Takahashi M; Tomioka N; Endo Y; Hosoda M; Doihara H; Miyoshi S; Yamashita H;
Breast Cancer Res; 2016 Jul; 18(1):73. PubMed ID: 27368476
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
[TBL] [Abstract][Full Text] [Related]
11. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
[TBL] [Abstract][Full Text] [Related]
12. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
[TBL] [Abstract][Full Text] [Related]
13. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis.
Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L
Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies.
Tao Y; Li H; Huang R; Mo D; Zeng T; Fang M; Li M
Cell Physiol Biochem; 2018; 46(4):1716-1726. PubMed ID: 29730663
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
Xie Q; Liang J; Rao Q; Xie X; Li R; Liu Y; Zhou H; Han J; Yao T; Lin Z
Ann Surg Oncol; 2016 Jan; 23(1):163-70. PubMed ID: 25916979
[TBL] [Abstract][Full Text] [Related]
18. CD24 Overexpression Related to Lymph Node Invasion and Poor Prognosis of Colorectal Cancer.
Wang JL; Guo CR; Su WY; Chen YX; Xu J; Fang JY
Clin Lab; 2018 Apr; 64(4):497-505. PubMed ID: 29739071
[TBL] [Abstract][Full Text] [Related]
19. The impact of Aldehyde dehydrogenase 1 expression on prognosis for metastatic colon cancer.
Fitzgerald TL; Rangan S; Dobbs L; Starr S; Sigounas G
J Surg Res; 2014 Nov; 192(1):82-9. PubMed ID: 24953984
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of SIRT1 expression in colorectal cancer: A systematic review and meta analysis.
Zu G; Ji A; Zhou T; Che N
Int J Surg; 2016 Feb; 26():32-7. PubMed ID: 26763348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
